ERBB2 and breast cancer: However, target deletion of PTEN leads to precocious development and neoplasia in the mammary gland using MMTV-Cre transgenic mice [25] and there appeared breast cancer in ErbB2/Neu-overexpressing/PTEN-deficient mice [26].